A franchise is only as strong as what sits behind it. Diagnex brings a proven protocol, a structural cost advantage, an owner-operator model and one clinical standard across every home.
Each of these is defensible on its own. Together they are the reason a Diagnex territory can deliver care to a metropolitan standard while remaining a sound business for the operator who runs it.
The clinical protocol was built by delivering the service across more than two hundred cases in real homes — not designed in theory. A partner operates a documented standard that already works.
Consumables are supplied through a healthcare group trusted since 1995 — genuine, quality-assured stock, at a cost an independent operator could not reach alone. Not a discount, and never a compromise on what enters the patient’s blood path.
The organised chains dispatch technicians from a central base. A Diagnex partner lives in the city they serve, hires their own team and holds their market exclusively — closer to patients, invested in the outcome.
Diagnex Core records every session and holds the protocol consistent across independently owned territories — so care is the same in one city as another. Consistency is the network's product.
Home haemodialysis lives or dies on consumables economics. A session's largest recurring cost is the consumables it consumes. An operator who buys them at an independent's price has almost no margin left after clinical and staffing costs. An operator who buys them through the group's supply chain has a real, durable margin at a price patients will pay.
A competitor can copy a website, a price list, even a protocol on paper. What they cannot quickly copy is the distribution relationships built since 1995 and the buying position that comes with them. That is the moat, and it is the partner's protection.
There is a second market in dialysis consumables in India — counterfeit and substandard stock, sold well below the genuine price. It is available to any operator who goes looking for it, and on a spreadsheet it makes the economics of a dialysis business look considerably better than they are.
Diagnex does not supply it, and a Diagnex partner does not buy it. Every dialyser, every bloodline, every concentrate supplied through the group is genuine, traceable to its manufacturer, and up to the standard of the treatment we have promised the patient. Consumables are sourced through the same licensed distribution chain the group has operated since 1995.
This matters commercially as much as clinically. A partner’s territory is built on families trusting an unfamiliar model of care inside their own home. That trust does not survive a single adverse event traced back to a counterfeit dialyser — not for that partner, and not for the network. Quality and standard are the differentiator Diagnex offers, and the reason the cost position is a real advantage rather than a race to the bottom.
What this means for a partner. The cost position comes from the group’s buying power, not from what is bought. A partner never has to choose between margin and the standard of care being delivered — which is exactly the choice an independent operator eventually faces.
A franchise partner is an operator, not a clinician — and is never asked to be one. The clinical authority in every territory sits with a panel that Diagnex builds and stands behind, so the partner’s job is to run the operation well while the medicine stays where it belongs.
Nephrologists set the clinical protocol every territory runs to, and take escalations from the partner’s team with the full session record already attached through Diagnex Core. This is the backstop a single independent operator cannot build alone.
Dialysis patients rarely present with kidney disease alone. Consulting specialists are empanelled to the network so that a partner’s patient reaches the right clinician through an established route, rather than whoever the family can find at short notice.
Each territory operates under a named supervising physician engaged on a defined clinical scope — protocol sign-off, availability for escalation, and periodic review of the territory’s cases. The engagement is a fixed monthly retainer for that scope.
What a partner is responsible for. Hiring and running the local team, the quality of the operation, and the relationship with families. Clinical judgement, protocol and escalation stay with the panel. That division is deliberate, and it is what makes the model workable for an operator without a medical background.
See exactly what the investment is and what it can return, or apply to secure your territory.
Territories are being allocated now — apply, or ask us anything over WhatsApp.